Citations - Hansen Torben F.

CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
CONCLUSIONS: Early therapeutic reconsideration is of utmost importance. A low level of meth-ctDNA after one cycle of chemotherapy in the first line setting is a potential marker for excellent clinical outcomes. The clinical utility should be confirmed in randomized clinical trials.... Read more
Published on: 2020-06-11
Source: Hansen Torben F.
By: Caroline B Thomsen
  • Other

    Citations

  • Other

    Citations

Translate »